Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
7.48
-0.07 (-0.86%)
Aug 25, 2025, 4:00 PM - Market closed
Passage Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
Cash & Equivalents | 57.63 | 37.57 | 21.71 | 34.6 | 128.97 | 135 | Upgrade |
Short-Term Investments | - | 39.18 | 92.59 | 155.01 | 186.81 | 169.82 | Upgrade |
Cash & Short-Term Investments | 57.63 | 76.76 | 114.29 | 189.61 | 315.77 | 304.82 | Upgrade |
Cash Growth | -37.21% | -32.84% | -39.72% | -39.95% | 3.59% | 91.86% | Upgrade |
Prepaid Expenses | 1.4 | 0.84 | 0.92 | 0.93 | 1.73 | 1.41 | Upgrade |
Other Current Assets | 1.29 | 1.22 | 2.74 | 6.51 | 7.57 | 10.96 | Upgrade |
Total Current Assets | 60.32 | 78.82 | 117.96 | 197.04 | 325.07 | 317.18 | Upgrade |
Property, Plant & Equipment | 18.61 | 23.13 | 32.15 | 42.24 | 23.81 | 2.8 | Upgrade |
Other Long-Term Assets | 0.27 | 0.46 | 0.43 | 4.27 | 6.2 | 8.03 | Upgrade |
Total Assets | 79.2 | 102.41 | 150.55 | 243.55 | 355.08 | 328.01 | Upgrade |
Accounts Payable | 2.4 | 0.74 | 1.3 | 4.07 | 9.45 | 5.27 | Upgrade |
Accrued Expenses | 4.07 | 6.71 | 9.67 | 10.93 | 19.39 | 15.37 | Upgrade |
Current Portion of Leases | 3.59 | 3.69 | 3.37 | 3.28 | - | - | Upgrade |
Other Current Liabilities | 9.74 | 8.23 | 2 | 0.09 | 0.66 | 0.54 | Upgrade |
Total Current Liabilities | 19.8 | 19.36 | 16.34 | 18.35 | 29.5 | 21.18 | Upgrade |
Long-Term Leases | 21.14 | 21.79 | 22.92 | 23.83 | - | - | Upgrade |
Other Long-Term Liabilities | - | - | - | - | 6.92 | 2.12 | Upgrade |
Total Liabilities | 40.94 | 41.15 | 39.26 | 42.18 | 36.42 | 23.29 | Upgrade |
Common Stock | - | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade |
Additional Paid-In Capital | 722.28 | 720.48 | 705.79 | 694.73 | 675.35 | 475.62 | Upgrade |
Retained Earnings | -684.03 | -659.24 | -594.47 | -492.41 | -356.28 | -170.9 | Upgrade |
Comprehensive Income & Other | - | 0.01 | -0.04 | -0.97 | -0.41 | -0.01 | Upgrade |
Total Common Equity | 38.26 | 61.26 | 111.28 | 201.37 | 318.66 | 304.71 | Upgrade |
Shareholders' Equity | 38.26 | 61.26 | 111.28 | 201.37 | 318.66 | 304.71 | Upgrade |
Total Liabilities & Equity | 79.2 | 102.41 | 150.55 | 243.55 | 355.08 | 328.01 | Upgrade |
Total Debt | 24.73 | 25.48 | 26.29 | 27.11 | - | - | Upgrade |
Net Cash (Debt) | 32.9 | 51.28 | 88 | 162.5 | 315.77 | 304.82 | Upgrade |
Net Cash Growth | -49.87% | -41.73% | -45.85% | -48.54% | 3.59% | 91.86% | Upgrade |
Net Cash Per Share | 10.61 | 16.98 | 32.15 | 59.71 | 118.39 | 157.87 | Upgrade |
Filing Date Shares Outstanding | 3.18 | 3.11 | 2.78 | 2.73 | 2.71 | 2.69 | Upgrade |
Total Common Shares Outstanding | 3.18 | 3.1 | 2.75 | 2.73 | 2.71 | 2.28 | Upgrade |
Working Capital | 40.51 | 59.45 | 101.62 | 178.69 | 295.57 | 296.01 | Upgrade |
Book Value Per Share | 12.04 | 19.74 | 40.51 | 73.74 | 117.49 | 133.60 | Upgrade |
Tangible Book Value | 38.26 | 61.26 | 111.28 | 201.37 | 318.66 | 304.71 | Upgrade |
Tangible Book Value Per Share | 12.04 | 19.74 | 40.51 | 73.74 | 117.49 | 133.60 | Upgrade |
Machinery | 1.51 | 11.67 | 11.68 | 12.87 | 12.05 | 0.78 | Upgrade |
Construction In Progress | - | - | 0.64 | 1.29 | 0.82 | 1.31 | Upgrade |
Leasehold Improvements | 7.39 | 7.39 | 10.21 | 13.51 | 13.41 | 1.64 | Upgrade |
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.